GLP-1 medications, particularly those like BrightMeds, are rapidly gaining prominence in the management of type 2 diabetes and are now being explored for obesity . These powerful drugs work by mimicking the body's natural incretin release, stimulating glucose-dependent insulin secretion and curbi